ICAM-1 and β2 Integrin Deficiency Impairs Fat Oxidation and Insulin Metabolism during Fasting
- 25 Downloads
Intercellular adhesion molecule 1 (ICAM-1) and β2 integrins play critical roles in immune responses. ICAM-1 may also participate in regulation of energy balance because ICAM-1-deficient mice become obese on a high-fat diet. We show that mice deficient in these adhesion receptors are unable to respond to fasting by up-regulation of fatty acid oxidation. Normal mice, when fasted, exhibit reduced circulating neutrophil counts and increased ICAM-1 expression and neutrophil recruitment in liver. Mice lacking ICAM-1 or β2 integrins fail to show these responses—instead they become hypoglycemic with steatotic livers. Fasting ICAM-1-deficient mice reduce insulin more slowly than wild-type mice. This produces fasting hyperinsulinemia that prevents activation of adenosine mono-phosphate (AMP)-activated protein kinase in muscles and liver, which results in decreased import of long chain fatty acids into mitochondria. Thus, we show a new role for immune cells and their adhesion receptors in regulating metabolic response to fasting.
Leukocyte adhesion molecules play an essential role in inflammation and immunosurveillance. Intercellular adhesion molecule-1 (ICAM-1) is a member of the immunoglobulin super family of adhesion molecules (1) that is expressed on many cell types including endothelium, hepatocytes, and leukocytes. Two main ligands for ICAM-1 are CD11a/CD18 (LFA-1) and CD11b/CD18 (Mac-1), which are members of the leukocyte-specific β2 integrin (CD18) family that comprises at least 2 other members. Mac-1 is expressed on monocytes, granulocytes, natural killer cells, and a subpopulation of T cells (2), whereas LFA-1 is expressed on all leukocytes (3). Mice deficient in ICAM-1 have impaired immune function and decreased inflammatory response, reflected in impaired activation and migration of leukocytes to places of inflammation, reduced contact hypersensitivity and impaired ability of spleen cells to act as stimulators in mixed lymphocyte responses (4). Mice deficient in CD18 expression showed impaired activation and migration of leukocytes to places of inflammation and impaired T cell proliferation in response to T-cell receptor activation that was more extensive than in ICAM-1-deficient mice (5). In humans, CD18 deficiency causes a severe immunodeficiency condition called Leukocyte Adhesion Deficiency Syndrome type I (LAD I) (6).
Participation in immune and inflammatory response is not the only role for ICAM-1 and CD18 molecules. Our laboratory previously showed that ICAM-1 or CD11b/CD18 deficiency in mice can result in spontaneous obesity in old age when mice are fed normal chow diet or obesity at a young age when mice are fed high-fat diet (7). This suggests a role for ICAM-1 and CD11b/CD18 molecules in regulation of energy balance. Regulation of energy intake does not appear to be affected in either ICAM-1 or CD11b-deficient mice because there was no significant difference in food consumption as compared with wild type, C57Bl/6J mice (WT). The presence of fatty livers in the older ICAM-1-deficient mice (7) suggested that leukocytes and their receptors might be involved in regulation of fat metabolism. Recently, 2 new reports were published describing a close connection between obesity and immune response (8,9). In obese adipose tissue of people and mice, there was significant infiltration by macrophages compared with adipose tissue from lean people and mice. One possibility is that macrophages are attracted by increased lipid content of the cells and try to fight unwanted fat accumulation (10).
During fasting, the basal metabolic rate is decreased and there is a shift in fuel utilization preference from carbohydrates and fat to almost entirely fat. During the switch from fed state to fasting, metabolic response is mediated by decreasing circulating insulin concentration and increasing concentration of counter regulatory hormones, such as glucagon, cortisol, epinephrine, and norepinephrine. This activates glycogenolysis, gluconeogenesis, and fat oxidation (11). The importance of fat metabolism in successful adaptation to fasting was best illustrated in peroxisome-proliferator activated receptor-α (PPARα)-deficient mice (12). PPARα is a nuclear hormone receptor that regulates expression of a number of genes involved in fat oxidation in the liver. Mice deficient in the expression of this master regulator of liver fat metabolism had liver steatosis, severe hypoglycemia, hypoketonemia, hypothermia, and elevated plasma free fatty acid (FFA) levels during fasting. The same mice did not show signs of significant metabolic derangement when they were fed normal chow diet (12).
In this study, we demonstrate that ICAM-1- and CD18-deficient mice have a similar metabolic phenotype to the PPARα-deficient mice. We show that leukocytes and thus the immune system help orchestrate the stress response to starvation by regulating insulin clearance.
Materials and Methods
Mice were housed on a 12-hour dark/12-hour light cycle. Eight- to eleven-week-old males were used and were provided unrestricted access to water and standard lab chow (Prolab 3000, PMI Feeds, Richmond, IN) containing 5.0% (wt/wt) fat, 55% (wt/wt) carbohydrate, and 22% (wt/wt) protein. ICAM-1- (4) and CD18-null mice (4,5) used in the experiments were backcrossed 8 times to C57Bl/6J background. Wild-type mice were C57Bl6/J. Preparations for fasting were usually initiated 24 h before onset of fasting. Metal grids were placed at the bottom of the cages, without changing of actual cages. Mice were given 24 h to adjust to this new environment before the fasting was initiated at 9:00 a.m., and the experiments were performed at 9:00 a.m., 24 h later. Experimental procedures were approved by the Animal Care and Use Committee of the CBR Institute for Biomedical Research.
Respiratory Quotient Measurement
We used an indirect open circuit calorimeter (Oxymax, Columbus Instruments, Columbus, OH). The device consists of 4 mouse chambers where a constant air flow (0.75 liters/min) is pulled through and monitored by a mass sensitive flow meter. The system monitors oxygen and carbon dioxide gases concentrations at the inlet and outlet of the sealed chambers containing the animals. This is used to compute oxygen consumption, carbon dioxide production, and respiratory quotient (RQ).
Blood for glucose measurements was taken from the tail vein. Otherwise, blood was drawn by retro-orbital puncture. Blood glucose was measured using Precision Xtra glucose analyzer (Medisense/Abbott, Abbott Park, IL). Plasma FFAs were determined using Wako NEFA C kit. β-hydroxybutyrate was determined using a kit from Sigma. Liver glycogen was determined by the anthrone method (13). Serum triglycerides were determined using a Wako L-Type TG H assay. Serum insulin was measured using ultrasensitive mouse insulin ELISA (ALPCO Diagnostics, Windham, NH). Serum C-peptide was measured using rat C-peptide radioimmunoassay (RIA) kit (Linco Research, St. Charles, MO). Acylcarnitine profile and total/free carnitine concentration in pooled plasma from fasted WT or ICAM-1-deficient mice was measured using tandem mass spectrometry at Duke University Biochemical Genetics Laboratory.
Staining and Counting of CD11b/CD18+ Cells in Liver Sections
Cryostat sections (10 µ/m) derived from the livers of mice sacrificed at 9 a.m. were fixed in acetone, air-dried, and incubated with rat anti-mouse Mac-1 (Boehringer-Mannheim, Mannheim, Germany) (1/100). The slides were incubated with biotinylated secondary rabbit anti-rat IgG (DakoCytomation, Carpinteria, CA) and visualized using streptavidin-peroxidase and substrate chromogen solution (Zymed, South San Francisco, CA). Numbers of CD11b/CD18+ cells represent average of results obtained by 2 observers blinded to genotype.
Western Blot Analysis
Phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) was determined using 4% to 15% gradient sodium dodecyl sulfide acrylamide gels (Bio-Rad, Hercules, CA) loaded with either 40 µg of the total muscle protein or 3 µg of the total liver protein. Proteins were transferred to Immobilon-P polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA) and labeled with antibodies against phosphopeptides surrounding Thr 172 of the α-subunit of human AMPK or an affinity-purified polyclonal antibody against AMPK-α (Cell Signalling, Beverly, MA) and Ser 79 of rat ACC (Upstate Biotech, Charlottesville, VA).
Unless stated otherwise, data are presented as mean ± SEM.
ICAM-1 or CD18 Deficiency Diminishes the Physiologic Change in Respiratory Quotient Produced by Fasting
The mild steatosis that usually occurs with fasting can be explained by the fact that uptake of FFAs into hepatocytes exceeds the capacity for oxidation and export of triacylglycerols (15). ICAM-1-deficient or CD18-deficient mice showed marked micronodular fatty infiltration of the liver after 24-h fasting, while in fasted WT livers, only the expected minor accumulation of lipid droplets was found (see Figure 1B). Thus deletion of either ICAM-1 or CD18 molecules leads to impaired fat metabolism during fasting.
Metabolic Defects Observed in ICAM-1-Deficient Mice
Metabolic parameters of fed and fasted WT and ICAM-1-deficient mice a
55.8 ± 5.1
38.7 ± 5.6
29.5 ± 6.2
88 ± 8.7
0.49 ± 0.04
0.63 ± 0.08
0.86 ± 0.07
1.19 ± 0.09
0.7 ± 0.05
0.8 ± 0.08
25.5 ± 1.6
8.8 ± 1.0
Glycogen (mg/100 g of liver tissue)
4333 ± 135
4703 ± 459
218.5 ± 49.7
37.92 ± 15.5
Fasting Stimulates Release of FFAs from Fat Stores into circulation
Serum FFAs were elevated in the fasted mice compared with fed mice. However, FFA level was significantly higher in fasted ICAM-1-deficient mice compared with fasted WT mice (Table 1). Greater FFAs in fasted ICAM-1-deficient mice could be caused by a lower uptake rate of FFAs by tissues and/or by the combination of decreased FFA uptake and decreased fat oxidation in these animals.
β-hydroxybutyrate is an important product of fatty acid oxidation in the liver. Formation of β-hydroxybutyrate is very low in the fed state and its serum level is greatly increased during fasting. Production of β-hydroxybutyrate in ICAM-1-deficient mice during fasting was 3-fold lower than in WT mice (Table 1). Again, this result is most consistent with the inability of ICAM-1-deficient livers to activate fat oxidation.
When an external source of glucose is absent, such as during fasting, glucose homeostasis is maintained by breakdown of glycogen and through gluconeogenesis in the liver from precursors supplied by liver, muscle, and adipose tissues. It is reasonable to expect that impaired fat oxidation during fasting would result in faster depletion of liver glycogen. We observed much lower liver glycogen content after fasting in ICAM-1-deficient mice. These results suggest that liver gluconeogenesis is impaired, causing more rapid glycogen depletion in ICAM-1-deficient mice compared with WT mice.
Changes in Leukocyte Distribution Induced by Fasting Are Modified in ICAM-1- or CD18-Deficient Mice
Serum Insulin and Glucose Concentrations in ICAM-1- and CD18-Deficient Mice during Fasting
Leukocyte Adhesion Affects Clearance of Insulin on Fasting
Blood insulin level is regulated by pancreatic insulin secretion and insulin clearance by peripheral tissues. Liver is the predominant organ clearing insulin during fasting (20). In a rat model, pancreatic insulin secretion and, consequently, portal insulin concentration shows very little diurnal variation while at the same time large differences exist in peripheral arterial and venous insulin levels (21). We hypothesized that fasting hyperinsulinemia in ICAM-1- and CD18-deficient mice may be due to impaired insulin clearance by the liver. We measured concentration of C-peptide, a pro-peptide released during biosynthesis of insulin, and insulin concentrations and calculated C-peptide/insulin ratio. Because C-peptide is cleared independently of insulin in the kidney (22), this ratio is used to estimate the liver’s ability to remove insulin (23). We observed a markedly lower C-peptide/insulin ratio in 24-h fasted ICAM-1-deficient compared with 24-h fasted WT mice (see Figure 4C). This was due to an increase in circulating insulin concentration because C-peptide levels between fasted WT (864.2 ± 127.6 pmol/L) and ICAM-1-deficient mice (1098.2 ± 326.4 pmol/L) were not different (P > 0.05, n = 9). The fed state C-peptide/insulin ratio in ICAM-1-deficient mice was similar to C-peptide/insulin ratio in corresponding fed WT mice (see Figure 4C). Our results indicate that the most likely mechanism of impaired insulin decrease during fasting is a defect in insulin clearance.
Consequences of High-Fasting Insulin Level on Key Enzymes Regulating Fat Metabolism
Our results demonstrate that deficiency of either ICAM-1 or CD18 impairs physiologic response to fasting. Fasted ICAM-1-deficient and CD18-deficient mice show impaired ability to oxidize fat. This is reflected in the development of liver steatosis and inappropriately low blood levels of ketone bodies and glucose (hypoketotic hypoglycemia). We have also seen excessive weight gain in mice lacking CD11b (αM integrin) (7) and, more recently, in mice overexpressing soluble ICAM-1, which acts as an inhibitor of leukocyte recruitment (Hong-Wei Wang, manuscript submitted for publication).
One of the earliest changes in immune response during fasting is neutropenia. However, fasted ICAM-1-deficient and CD18-deficient mice do not become neutropenic. Failure to develop fasting neutropenia coincides with the failure of fasted ICAM-1-deficient mice to recruit neutrophils to the liver. ICAM-1-deficient and CD18-deficient mice exhibit fasting hyperinsulinemia, which is most likely caused by impaired liver insulin clearance during fasting (see Figure 4C). Indeed, we established for ICAM-1-deficient mice that hyperinsulinemia caused decreased AMPK phosphorylation in muscle and liver resulting in decreased import of long chain fatty acids into mitochondria and impaired fat oxidation. Thus, ICAM-1 and CD18 leukocyte adhesion receptors are necessary for the regulation of whole body fat oxidation and overall energy balance (see Figure 1A) during fasting.
The 2 main causes of fasting hypoketotic hypoglycemia in people are (1) inborn errors of fatty acid oxidation and ketone body production and (2) hyperinsulinemia. The defect in fat oxidation observed in ICAM-1- and CD18-deficient mice is in many ways similar to the fat oxidation defect observed in PPARα-deficient mice. Fasted PPARα-deficient mice show accumulation of lipid in their livers. At the same time they display hypoglycemia, hypoketonemia, and elevated plasma FFA levels, indicating inhibition of fatty acid uptake and oxidation in the liver (12). Several lines of evidence argue against errors affecting expression of enzymes of the PPARα-regulated pathway of fatty oxidation being the cause of metabolic defect in ICAM-1-deficient and CD18-deficient mice. We did not detect significant differences in fasting mRNA expression levels of either PPARα or acetyl-CoA oxidase and liver form of fatty acid binding protein, genes known to be regulated by PPARα (27), between WT and ICAM-1-deficient mice. Additionally, the in vitro ability of liver mitochondria to oxidize exogenously supplied short and long chain fatty acids to β-hydroxybutyrate was not significantly different between WT and ICAM-1-deficient mice (not shown). Similarly, we did not detect any differences in PPAR-γ levels, the nuclear receptor involved in adipogenesis (unpublished observation).
An alternative mechanism by which fat oxidation could be inhibited in fasting mice is hyperinsulinemia. Upon stimulation by nutrient secretagogues, insulin is co-secreted with C-peptide by the pancreatic β cells in equimolar amounts into portal circulation (28). Liver is the principal site where insulin is enzymatically degraded and cleared from the circulation. In contrast to insulin, C-peptide is not significantly extracted by the liver and its metabolic clearance rate is fairly constant (22,23). Therefore, clinical studies of insulin clearance use circulating C-peptide/insulin molar ratios as an index of hepatic insulin uptake (22). Several lines of evidence suggest that insulin clearance by the liver is a regulated process markedly stimulated by fasting. In humans, oral glucose administration decreases hepatic extraction of insulin as indicated by a decrease of C-peptide insulin ratio (29). Furthermore, experiments using a perfused rat pancreas-liver preparation showed that the activity of liver in degradation of insulin changes from close to 0% in the fed state to 45% in the fasted state (30). After 24-h fasting, both ICAM-1-deficient and CD18-deficient mice had serum insulin concentrations that did not differ significantly from their fed state. At the same time, fasted WT mice decreased their insulin concentration several fold compared with their fed serum insulin concentration (see Figure 4A). C-peptide concentration was not significantly different between WT and ICAM-1-deficient mice. In contrast, C-peptide/insulin molar ratio is significantly lower in ICAM-1-deficient mice compared with WT (see Figure 4C). Together, these findings suggest failure of insulin clearance as the possible cause of fasting hyperinsulinemia in ICAM-1-deficient mice and likely in CD18-deficient mice as well. In addition, the high levels of insulin in these mice explain why their body is not responding to fasting in the expected way. Insulin is indeed a very powerful regulator of metabolism. We injected insulin into fasting wild-type mice while in the metabolic chamber and their RQ transiently increased to fed-state levels (unpublished observation).
Because both ICAM-1-deficient and CD18-deficient mice have a similar defect in fat oxidation and insulin metabolism, it is reasonable to suspect that interaction between ICAM-1 and CD18, such as occurs during leukocyte adhesion, is required for physiologic regulation of insulin metabolism and fat oxidation. The fact that CD18 (β2 integrin) is a leukocyte-specific integrin implicates leukocytes and, with them, the immune system in metabolic response to fasting. Recent reports of macrophage accumulation in adipose tissue from obese people and mice (8,9) together with this report may show a new paradigm in the role of immune system in regulation of fat metabolism.
Hyperinsulinemia can inhibit fat oxidation directly through inhibition of intracellular fat oxidation pathways and indirectly through regulation of FFA availability (31). In ICAM-1-deficient mice FFA availability is not impaired (Table 1). Alternatively, examination of the free carnitine and acyl-carnitine concentrations in plasma of fasted WT and ICAM-1-deficient mice suggested decreased CPT I activity. To confirm this mechanism, we measured phosphorylation level of AMPK and ACC that together control fatty acid import into mitochondria (32). Insulin antagonizes activation of AMPK and in that way inhibits phosphorylation of downstream targets of AMPK (26,31). One of the main targets of AMPK is ACC that produces malonyl-CoA, which allosterically inhibits CPT I, the main enzyme for transport of long-chain fatty acids into mitochondria. Decreased phosphorylation of ACC by AMPK sustains malonyl-CoA production and ultimately decreases fat oxidation. Our results suggest that AMPK is less active in both fasting muscle and liver cells of ICAM-1-deficient mice (see Figure 5).
Metabolic abnormalities in ICAM-1-deficient and CD18-deficient mice can be directly related to recently described hyperinsulinemia and hypoglycemia in a family with LAD I (6). LAD I is an autosomal-recessive hereditary disorder characterized by CD18 deficiency resulting in delayed umbilical cord separation, persistent granulocytosis, recurrent cutaneous abscesses, and periodontal infections, and bacterial sepsis (33). The finding of a similar metabolic phenotype in both mice and people with deficiency of the same leukocyte adhesion molecule suggests evolutionary conservation of a mechanism for leukocyte-mediated regulation of fat oxidation during fasting.
The mainstream view of regulation of metabolism during fasting holds that lack of food leads to decreased pancreatic secretion of insulin due to falling blood glucose concentration which then represents the critical signal for increase of fat oxidation. However, several reports published in the late 1970s and early 1980s suggested that, in addition, the liver had an important role in decreasing peripheral insulin concentration in the early stages of fasting, thereby helping the body to adjust to fasting stress (21,30). Our work supports the importance of insulin degradation in the normal response to fasting and furthermore suggests that this is a highly regulated process in which innate immune response plays an important role. Recently, the focus has shifted from the view of hyperinsulinemia as a compensatory mechanism for peripheral insulin resistance to an alternative view in which hyperinsulinemia in some cases could be the primary metabolic abnormality causing obesity (34), possibly through inhibition of lipolysis (35). Furthermore, emerging evidence suggests that hyperinsulinemia can cause accumulation of β-amyloid in the brain and in doing so significantly increases the risk of Alzheimer’s disease (36). With a growing interest in developing therapeutic options for treatment of obesity and Alzheimer’s disease, a deeper understanding of this new mechanism of insulin homeostasis regulated by leukocytes and their adhesion receptors will have future clinical significance.
We thank Barbara Corkey, Jeffrey Friedman, Ronald Kahn, and Harvey Lodish for helpful discussions and the many scientists who patiently listened to our story and gave us advice. We thank Leonardo Ganem for PPAR analysis. The work was supported by National Heart, Lung, and Blood Institute/NIH grant RO1-HL53756 to DDW.TWF was supported by a research stipend from the Deutsche Forschungsgemeinschaft (FE 537/1-1).